CATHERINE MIRANDA: Open Payments
NPI 1942547294 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,439 in 112 payments from 20 companies in 2025. Trend: 2023 $1,157 · 2024 $1,423 · 2025 $2,439
Food & beverage: $2,439
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $362 |
| ABBVIE INC. | 17 | $348 |
| Lilly USA, LLC | 12 | $318 |
| Novartis Pharmaceuticals Corporation | 18 | $285 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $207 |
| Otsuka America Pharmaceutical, Inc. | 11 | $187 |
| PFIZER INC. | 14 | $172 |
| Corcept Therapeutics | 5 | $104 |
| GlaxoSmithKline, LLC. | 2 | $100 |
| Exact Sciences Corporation | 2 | $69 |
Products named: VRAYLAR, LEQVIO, AIRSUPRA, JARDIANCE, REXULTI, MOUNJARO, FARXIGA, Korlym.
Industry payments across CA — which companies pay providers there.
